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Abstract 
Background To evaluate whether clinical features from the history, presentation, physical and 
neurological examination of dogs with cervical hyperaesthesia are statistically predictive of 
the underlying diagnosis.   
 
Methods Two hundred and ninety-eight dogs presenting with cervical hyperaesthesia between 
January 2010 and October 2018 were investigated. Only neurologically normal dogs with 
cervical hyperaesthesia on examination were included, while those with concurrent 
neurological deficits including gait abnormalities and proprioceptive deficits were excluded. 
Univariate analysis of clinical variables was performed and those associated with each 
diagnosis were retained for multivariable binary logistic regression models.  
 
Results Ninety-five percent of cervical hyperaesthesia presentations were represented by 
eight conditions which included steroid-responsive meningitis arteritis (SRMA, n=100), 
intervertebral disc extrusion (IVDE, n= 78), syringomyelia (SM, n= 51), intervertebral disc 
protrusion (IVDP, n= 30), neoplasia (n=8), cervical spondylomyelopathy (CSM, n=7), 
immune mediated polyarthritis (IMPA, n= 5) and meningoencephalomyelitis of unknown 
aetiology (MUA, n=5). Younger age (p=0.003), pyrexia (p=0.003), and haematology 
abnormalities (p=0.03) comprising leucocytosis, neutrophilia or monocytosis, were 
associated with a diagnosis of SRMA. 
 
Conclusions Easy-to-recognise clinical features can be used to identify the most likely 
differential diagnosis in neurologically normal dogs with cervical hyperaesthesia, which may 
aid the decision making of veterinary surgeons evaluating dogs with this presentation.  
 
Abbreviations:  
CSM: Cervical spondylomyelopathy 
IMPA: Immune mediated polyarthritis 
IVDE: Intervertebral disc extrusion 
IVDP: Intervertebral disc protrusion 
MUA: Meningoencephalomyelitis of unknown aetiology 
SM: Syringomyelia 
SRMA: Steroid responsive meningitis arteritis 
 
Introduction 
The assessment of dogs with cervical hyperaesthesia as the primary presenting characteristic 
is a common but potentially challenging occurrence for the veterinary practitioner. Signs of 
cervical discomfort can be identified from the patient’s head carriage, response to palpation 
of the cervical musculature or resistance to manipulation of the head (1). While cervical 
hyperaesthesia may be appreciated, it is merely a clinical sign and not specific to an 
underlying diagnosis. Owing to the wide range of anatomic structures in the cervical region, 
the source of pain can be difficult to locate and is dependent upon the type of potential 
disease process and the structure affected (2). Although, the majority of conditions leading to 
signs of cervical hyperaesthesia are related to neurological structures in the neck, clinical 
signs secondary to intracranial neurological disease such as brain tumours and 
hydrocephalus, and non-neurological cervical conditions including subcutaneous 
abscessation and trauma have been reported (3). Several disorders causing cervical 
hyperaesthesia have been documented in dogs which are associated with different diagnostic 
approaches, treatment options and hence prognoses (2).  
 
Degenerative disease of the intervertebral discs resulting in extrusion is widely regarded as 
one of the most frequent causes of cervical hyperaesthesia (4). It has been suggested that the 
larger diameter of the vertebral canal in this region means that affected dogs are more likely 
to present with signs of hyperaesthesia only, rather than paresis or ataxia commonly seen 
with intervertebral disc extrusion in the thoracolumbar region (5).  Inflammatory conditions, 
specifically steroid responsive meningitis arteritis (SRMA) and meningoencephalomyelitis of 
unknown aetiology (MUA) are widely recognised causes of cervical hyperaesthesia, 
particularly within young animals (6-8). Other frequently reported conditions include 
anomalies such as syringomyelia (SM) typically associated with Chiari-like malformation, 
cervical spondylomyelopathy (CSM), atlantoaxial subluxation, neoplasia and spinal fracture 
and luxation (9-12).  
 
Given the difficulty of narrowing down the underlying cause of cervical hyperaesthesia into a 
prioritised list of differential diagnoses, it is unsurprising that these cases are frequently 
referred to neurology specialists. However, referral and advanced diagnostics are not always 
an option, therefore the application of clinical reasoning to obtain a prioritised list of most 
likely diagnoses to guide investigation and treatment is of importance. Previous studies have 
shown that many canine and feline spinal disorders are statistically associated with 
characteristic combinations of clinical features (13, 14). The aim of this study was therefore 
to evaluate whether discrete clinical parameters from the history, presentation, physical and 
neurological examination of dogs presenting with cervical hyperaesthesia without concurrent 
neurological deficits could be used to statistically predict the most likely differential 
diagnoses. It was hypothesised that statistical models could be used to identify associations 
between discrete clinical characteristics and the most common diagnoses. This statistically 
validated information could be implemented by veterinary surgeons evaluating neurologically 
normal dogs with cervical hyperaesthesia to aid clinical decision making.  
 
Methods 
Ethical approval for this retrospective study was granted by the Royal Veterinary College 
Social Sciences Research Ethical Review Board (RVC; SR2018-1634). The digital medical 
database of the Small Animal Referral Hospital, Royal Veterinary College, was searched to 
retrieve the records of all dogs presenting with cervical hyperaesthesia between January 2010 
and October 2018. Cases presenting with cervical hyperaesthesia in the absence of concurrent 
neurological deficits were included. These cases were localised as neurologically normal with 
cervical hyperaesthesia on neurological examination. Dogs presenting with evidence of a 
myelopathy, including proprioceptive deficits and gait abnormalities such as ataxia or 
tetraparesis, or those with neurological examination changes suggestive of a forebrain or 
brainstem neurolocalisation, including cranial nerve or mentation changes were excluded. 
Dogs with incomplete medical records or cases in which a diagnosis was not reached were 
excluded from the study. 
 
Cases were required to have undergone a complete neurological examination with 
appropriate diagnostics to obtain a definitive diagnosis. The diagnostics performed were 
decided on an individual case basis by the attending board certified neurologist which 
included: spinal radiographs, CT, MRI, cerebrospinal fluid analysis, blood tests including 
haematology, biochemistry and infectious disease testing, cytology or histopathology if 
indicated. When performed, MRI, CT and radiographic studies were reviewed by a board-
certified neurologist. CT was performed with a 16-slice helical scanner (PQ 500, Universal 
systems, Solon; GE Healthcare) under sedation or general anaesthesia. MRI was performed 
with a high field unit (1.5 T, Intera; Phillips Medical Systems) under general anaesthesia. 
Guidelines for the MRI characterisation of intervertebral disc extrusion (IVDE)(15-18), 
intervertebral disc protrusion (IVDP)(17, 19), neoplasms (9, 20-22) and SM (23, 24) were 
used in making a radiological diagnosis. Cases of osseous-associated and disc associated 
cervical spondylomyelopathy (CSM) were grouped together and diagnosed based on 
previously reported MRI criteria (25, 26). Ancillary diagnostics tests, including CSF analysis 
and arthrocentesis, were performed when reaching a diagnosis of SRMA (6, 27), MUA (28, 
29) and immune mediated polyarthritis (IMPA) (30) in accordance with previously reported 
diagnostic guidelines. Diagnoses with three or fewer cases, such as vertebral fractures, 
discospondylitis, atlantoaxial instability, subarachnoid diverticula, hydrated nucleus pulposus 
extrusion and myositis were grouped as ‘other’ for inclusion in statistical analysis.  
 
For all cases the following information was collected from medical records: signalment 
including age, breed, sex, neuter status and weight, clinical history including onset and 
duration of clinical signs, disease progression, general physical and neurological examination 
abnormalities and findings from diagnostic investigations including blood tests and imaging. 
Onset of clinical signs was categorised into acute (<10 days) and chronic (>10 days). 
Progression of clinical signs was categorised into episodic, deteriorating, static or improving 
based upon the clinical history from the referring veterinary surgeon and owner. Clinical 
signs were termed lateralised when the board-certified neurologist deemed there to be an 
unequivocal difference in the severity of response to left and right lateral flexion of the neck. 
On physical examination, pyrexia was determined by a rectal temperature >39.2oC. The 
presence of a leucocytosis (>17.1 x109/L), neutrophilia (>11.5 x109/L) or monocytosis (> 1.5 
x109/L) on blood tests were grouped as haematological abnormalities (31).  
 
Statistical analysis was performed using statistical software (SPSS V.25.0.0.1; IBM). 
Univariate analysis of all clinical variables was performed for each diagnosis. Variables with 
P <0.30 were retained and a logistic regression, using the forced entry method, performed for 
each of the most prevalent diseases. The small sample size of the majority of breeds limited 
the performance of logistic regression for this variable. Variables retained in the final models 
were considered significant with a P <0.05 (32). A false discovery rate for multiple 
comparisons was performed on the resultant P values (33). Sensitivity and specificity 
calculations were performed for the presence of haematological abnormalities and pyrexia in 
SRMA cases (34). Results are presented with odds ratios (OR) and 95 percent confidence 
intervals (CI) for each condition compared to the rest of the study population (controls were 
those not diagnosed with the condition being modelled) (32). Non-normally distributed 
continuous data are presented as median (range) while normally distributed data are 
presented as mean (Standard deviation). 
 
Results 
Three hundred and nineteen dogs presented with cervical hyperaesthesia without evidence of 
concurrent neurological deficits during the study period. Five dogs were excluded due to 
incomplete clinical records. A further sixteen dogs were excluded from the study due to a 
diagnosis not being reached. These dogs typically presented with mild presentations of 
cervical hyperaesthesia which had demonstrated significant improvement with symptomatic 
medical treatment prior to presentation and therefore further diagnostics were not performed.  
 
Two hundred and ninety-eight dogs were therefore included in the study. The study 
population consisted of 170 males (104 neutered) and 128 females (87 neutered). The ages of 
these dogs ranged from 4 months to 14 years (median 3 years) while weights ranged from 
2kg to 62.4 kg (median 12.5kg). The study population consisted of 54 different breeds with 
38 cross breeds. The most prevalent breeds were Cavalier King Charles Spaniels (n=49), 
French Bulldogs (n=31), Beagles (n=27), Labradors (n=18) and Cocker Spaniels (n=10). Of 
the French Bulldogs within the study population, 84% (n=26) were diagnosed with IVDE 




The most commonly diagnosed condition was SRMA (n= 100; 33.6%), followed by IVDE 
(n= 78; 26.2%), SM (n= 51; 17.1%), IVDP (n= 30; 10.1%), neoplasia (n=8; 2.7%), CSM 
(n=7; 2.3%), IMPA (n= 5; 1.7%) and MUA (n=5; 1.7 %). Of the remaining dogs three were 
diagnosed with atlantoaxial instability or luxation and hydrated nucleus pulposus extrusion 
respectively, two dogs were diagnosed with cervical vertebral fractures, cervical myopathies 
and discospondylitis respectively. A single dog was diagnosed with a bacterial meningitis and 
another with a spinal arachnoid diverticulum (Table 1).  
 
Age 
Age was significantly associated with diagnoses of IVDP, neoplasia and SRMA. A diagnosis 
of IVDP or neoplasia was associated with older age, while dogs with SRMA were more 
likely to be younger (Table 2).  
 
Sex/ Neuter status 
Neuter status was associated with a diagnosis of IVDE, with the diagnosis being significantly 
more likely in male neutered and female neutered dogs (Table 2).  
 
Weight 
The weight of the patient was significantly associated with diagnoses of IVDE, SM and 
CSM. A diagnosis of SM was associated with dogs <10kg, IVDE was more likely in dogs 
weighing 10-25kg while CSM was more likely in dogs >40kg (Table 2).  
 
Onset and progression of clinical signs 
Onset of clinical signs was associated with diagnoses of IVDE, SM, IVDP and CSM, while 
the progression of clinical signs was associated with MUA. Dogs with IVDE more likely had 
an acute onset of clinical signs, while dogs diagnosed with IVDP, CSM and SM were more 
likely to have a chronic disease course. Progression of clinical signs was significantly 
associated with MUA which was more likely to be deteriorating (Table 2).  
 
Body Temperature 
The presence of pyrexia was significantly associated with SRMA with a sensitivity of 81 
percent and specificity of 97.5 percent for the diagnosis. Dogs with IVDE were significantly 
less likely to have a pyrexia on examination (Table 2).  
 
Blood test findings 
Compared with other diagnoses, dogs with SRMA and IMPA were more likely to have 
abnormal haematological values including leucocytosis, neutrophilia or monocytosis.  
Conversely, dogs with IVDE were significantly less likely to have such abnormalities on 
blood work (Table 2). The presence of leucocytosis, neutrophilia or monocytosis grouped as 
haematology abnormalities was found to have 65 percent sensitivity and 92.9 percent 
specificity for an SRMA diagnosis. When combined with the presence of pyrexia, the 
specificity increased to 99.5 percent with a decrease in sensitivity to 55 percent.   
Table 1: Summary of presentation, neurological examination and investigation findings for diagnoses with 5 or more cases 
 









Presentation Examination Investigation  









ME: 38 (38.0%) 
MN: 21 (21.0%) 
FE: 23 (23.0%) 
FN: 18 (18.0%) 
S: 34 (34.0%) 
M: 57 (57.0%) 
L:  8 (8.0%) 
XL: 1 (1.0%) 
A: 90 (90.0%) 
C: 10 (10.0%) 
D: 89 (89.0%) 
S: 8 (8.0%) 
E:  3 (3.0%) 
I:   0 (0.0%) 






ME: 10 (12.8%) 
MN: 35 (44.9%) 
FE: 4 (5.1%) 
FN: 29 (37.2%) 
S: 23 (29.5%) 
M: 46 (59.0%) 
L:  9 (11.5%) 
XL: 0 (0.0%) 
A: 58 (74.4%) 
C: 20 (25.6%) 
D: 65 (86.0%) 
S: 0 (0.0%) 
E:  13 (16.7%) 
I:    0 (0.0%) 
9% 3% 3% 
Syringomyelia (SM) 51 17.1 
4.0 
(0.5-11.0) 
ME: 9 (17.6%) 
MN: 18 (35.3%) 
FE: 11 (21.6%) 
FN: 13 (25.5%) 
S: 33 (64.7%) 
M: 17 (33.3%) 
L:  1 (2.0%) 
XL: 0 (0.0%) 
A: 7 (13.7%) 
C: 44 (86.3%) 
D: 14 (27.5%) 
S: 0 (0.0%) 
E:  37 (72.5%) 
I:   0 (0.0%) 






ME: 2 (6.7%) 
MN: 12 (40.0%) 
FE: 1 (3.3%) 
FN: 15 (50.0%) 
S: 15 (50.0%) 
M: 9 (30.0%) 
L:  6 (20.0%) 
XL: 0 (0.0%) 
A: 10 (33.3%) 
C: 20 (66.7%) 
D: 16 (53.3%) 
S: 2 (6.7%) 
E: 12 (40.0%) 






Neoplasia 8 2.7 
9.0 
(7.0-12.0) 
ME: 1 (12.5%) 
MN: 3 (37.5%) 
FE: 0 (0.0%) 
FN: 4 (50.0%) 
S: 0 (0.0%) 
M: 3 (37.5%) 
L:  4 (50.0%) 
XL: 1 (12.5%) 
A: 2 (25.0%) 
C: 6 (75.0%) 
D: 6 (75.0%) 
S: 0 (0.0%) 
E:  2 (25.0%) 
I:   0 (0.0%) 








ME: 1 (14.3%) 
MN: 4 (57.1%) 
FE: 0 (0.0%) 
FN: 2 (28.6%) 
S: 0 (0.0%) 
M: 2 (28.6%) 
L:  2 (28.6%) 
XL: 3 (42.9%) 
A: 1 (14.3%) 
C: 6 (85.7%) 
D: 2 (28.6%) 
S: 0 (6.1%) 
E:  5 (71.4%) 
I:   0 (0.0%) 
43% 14% 0% 
Meningoencephalomyelitis 





ME: 0 (0.0%) 
MN: 2 (40.0%) 
FE: 0 (0.0%) 
FN: 3 (60.0%) 
S: 4 (80.0%) 
M: 1 (20.0%) 
L:  0 (0.0%) 
XL: 0 (0.0%) 
A: 4 (80.0%) 
C: 1 (20.0%) 
D: 3 (60.0%) 
S: 2 (40.0%) 
E:  0 (0.0%) 
I:   0 (0.0%) 






ME: 0 (0.0%) 
MN: 1 (20.0%) 
FE: 1 (20.0%) 
FN: 3 (60.0%) 
S: 0 (0.0%) 
M: 5 (100.0%) 
L:  0 (0.0%) 
XL: 0 (0.0%) 
A: 5 (100.0%) 
C: 0 (0.0%) 
D: 5 (100.0%) 
S: 0 (0.0%) 
E:  0 (0.0%) 
I:   0 (0.0%) 
0% 40% 80% 
Other 14 4.7 
5.5 
(0.4-8.0) 
ME: 5 (35.7%) 
MN: 8 (57.1%) 
FE: 1 (7.1%) 
FN: 0 (0.0%) 
S: 3 (21.4%) 
M: 6 (42.9%) 
L:  3 (21.4%) 
XL: 2 (14.3%) 
A: 10 (71.4%) 
C: 4 (28.6%) 
D: 10 (70.5%) 
S: 0 (0.0%) 
E:  4 (28.6%) 
I:   0 (0.0%) 
14% 0% 14% 
ME= Male Entire, MN= Male Neutered, FE= Female Entire, FN= Female Neutered, S = <10kg, M= 10-25kg, L = 25-40kg, XL= >40kg, A = Acute, C = Chronic, D= Deteriorating, S= Static, E = Episodic, I= 
Improving, NN = Neurologically normal with cervical hyperaesthesia C1 = C1-C5, C6= C6-T2, FB = Forebrain/ Brainstem 
 







































Where statistically significant (P≤0.05) data presented include Odds Ratios with 95% confidence intervals (CI) indicated in parentheses and the comparison group for 
categorical data. Characteristics with no statistically significant bias are indicated with ‘-’























P = 0.04 





cf. male entire 
10-25kg  
2.8 (1.3-5.9) 















Syringomyelia (SM) 51 - - 
<10kg 
3.2 (1.4-7.4) 

















P = 0.003 














7 - - 
>40kg 
83.3 (6.5-1000.0) 













of unknown aetiology 
(MUA) 
5 - - - - - 
Deteriorating 
13.9 (2.1-90.9) 





5 - - - - - - 
Abnormal 
19.5 (1.8-210.6) 
P = 0.02 
cf. normal 
Discussion 
While cervical hyperaesthesia is frequently appreciated on clinical examination, formulating 
a diagnostic and treatment plan can be daunting, owing to the extensive list of differential 
diagnoses and numerous anatomic structures within the region (2). Using clinical information 
from the patient’s presentation in a problem-orientated approach has been advocated to 
provide a framework for clinical decision making (35). With the innate variability of 
presentations in veterinary medicine the approach to managing patients with cervical 
hyperaesthesia can never be reduced to a simple algorithm. However, the benefits of a 
clinical reasoning-based approach in the management of neurological presentations has been 
previously documented in canine and feline spinal disease and epilepsy (13, 14, 36, 37). 
 
This study evaluated whether discrete clinical features can be used to identify the most likely 
differential diagnoses in neurologically normal dogs presenting with cervical hyperaesthesia. 
Our results suggest that the most frequent causes of canine cervical hyperaesthesia are 
associated with discrete clinical characteristics obtained from the patient’s signalment, 
clinical history, general physical and neurological examinations. Although a wide range of 
diagnoses were evident within the study population, the eight most prevalent causes of 
cervical hyperaesthesia represented 95% of presentations. Furthermore, three quarters of dogs 
within the population were diagnosed with one the three most prevalent diagnoses, SRMA 
(34%), IVDE  (26%), and  SM (17%), which is consistent of the findings of previous research 
(3).  
 
A diagnosis of SRMA was associated with younger age, 63 times the odds of presenting with 
pyrexia and 6 times the odds of presenting with leucocytosis, neutrophilia or monocytosis on 
haematology. The predisposition of SRMA in juvenile dogs is not unexpected with the 
typical age of onset reported to be younger than 24 months of age (38, 39). The association of 
SRMA with pyrexia supports the findings of previous research in which SRMA was the most 
frequently diagnosed condition in a study of juvenile dogs with pyrexia (40). Haematology 
changes consistent with inflammation, including neutrophilia and leucocytosis, have been 
previously reported in the literature in association with SRMA (6, 41). The association with 
these clinical features is unsurprising, given the recognised definition of SRMA as a systemic 
immune disorder that is characterised by inflammatory changes of the leptomeninges and the 
associated vasculature (6).  
 
In the current study population, the presence of pyrexia had a higher sensitivity (81%) and 
specificity (97.5%) for a diagnosis of SRMA, than the presence of haematology 
abnormalities. When considering dogs presenting with a combination of pyrexia and 
haematology abnormalities the specificity for a diagnosis of SRMA further increased 
(99.5%), with a concurrent decrease in sensitivity (55%). Therefore, in dogs presenting with 
cervical hyperaesthesia and a combination of pyrexia and haematology abnormalities the 
clinician should be highly suspicious of an underlying diagnosis of SRMA. This information 
can be utilised to guide clinical reasoning including the formulation of an appropriate 
diagnostic and treatment plan for these patients. This can be particularly important in 
situations with financial constraints where a diagnosis can be reached with targeted 
diagnostics without performing costly advanced imaging. Although, the high specificity of 
these clinical variables means that the risk of reaching a false positive diagnosis is low, 
confirmatory diagnostics tests should be performed prior to treatment. This is important when 
considering the prolonged course of immunosuppressive corticosteroid treatment required 
with SRMA and the potential side effects of the medication. While pyrexia and haematology 
abnormalities are useful clinical variables for SRMA, the low sensitivity means that a 
diagnosis of SRMA cannot be excluded in cases presenting without pyrexia or haematology 
abnormalities.  
 
Consistent with previous literature, IMPA was also found to be significantly associated with 
the presence of abnormalities on haematology (30). When faced with compatible 
haematological abnormalities, in the presence or absence of pyrexia, the clinician is well 
advised to thoroughly examine the patient for evidence of joint pain or swelling as an 
indicator of IMPA. This is particularly prudent as previous reports have documented the 
prevalence of concurrent SRMA and IMPA to be as high as 46% (42). Identification of joint 
changes, therefore enabling a diagnosis to be obtained from arthrocentesis, can be less 
technically challenging for the clinician and represent a reduced risk to the patient compared 
with cerebrospinal fluid collection. IVDE was most frequently evident in smaller dogs, 
weighing between 10-25kg, most commonly with an acute onset of clinical signs, which 
reflects the findings of previous studies (13, 43). Dogs presenting with IVDE were typically 
systemically well with the diagnosis associated with 24 times the odds of having a normal 
body temperature and 17 times the odds of having normal blood work. There was no 
consistent lateralisation of signs noted. Increased odds for a diagnosis of IVDE was evident 
in both male and female neutered dogs. This finding aligns with the results of previous 
research which reported an increased risk of IVDE in neutered dogs, particularly when 
gonadectomy was performed at an early age (44, 45). Data regarding the age at which 
neutering was performed was not consistently available for our study population which 
limited further investigation into the impact of neutering timing. Of the French Bulldogs 
presented with cervical hyperaesthesia, 84% were diagnosed with IVDE, which is consistent 
with results of a previous studies (46).    
 
CSM, IVDP and SM all presented with a chronic onset of clinical signs. Unsurprisingly, dogs 
presenting with CSM typically weighed >40kg while SM patients were typically <10kg. This 
finding is expected given the known breed predispositions of both diseases (10, 11, 47). 
Further support is given by the fact that 88% of Cavalier King Charles Spaniels presenting 
with cervical hyperaesthesia during the study period were diagnosed with SM. SM was most 
commonly episodic in its progression. Although, the most obvious clinical signs to the owner 
such as phantom scratching or vocalisation may be intermittent or episodic, recent research 
has identified that persistent signs of discomfort including reduced activity, reluctance to 
jump or climb stairs, emotional changes and aversions to being touched are common in dogs 
with Chiari-like malformation and SM (48).  There was no statistical association between 
CSM and age in this study. Age predilections of osseous and disc associated CSM have been 
reported in the literature, however it is likely that there were not evident within this study as 
CSM was not separated into osseous or disc associated forms for analysis (25, 49).  
 
This study is invariably limited by its retrospective design. The study focused on clinical 
reasoning in dogs which were neurologically normal with cervical hyperaesthesia, with 
stringent exclusion of dogs that presented with concurrent neurological signs such as ataxia 
or tetraparesis. The study population therefore represents a specific clinical presentation and 
as a result the prevalence of each diagnosis and clinical reasoning findings correlate to 
neurologically normal dogs with cervical hyperaesthesia. The clinical reasoning outcomes 
may not be representative of dogs presenting with a myelopathy or neck problems in general. 
The exclusion of cases without a diagnosis aimed to provide accurate statistical results but 
may have selected against mild disease presentations which demonstrate improvement with 
symptomatic treatment. However, those cases which resolve with symptomatic medical 
treatment are not typically the cases in which a clinical reasoning approach or framework are 
required by the clinician. It must be considered that the study population represents cases 
presented to a referral hospital. This is inherently biased to more severe clinical presentations 
or conditions where specialist input is deemed necessary and therefore is unlikely to be 
representative of the disease prevalence seen in general practice. There is currently no 
information within the literature to compare prevalence of disorders causing cervical 
hyperaesthesia in this study to those seen in first opinion practice. All cases presented for 
cervical hyperaesthesia within the study window that met the criteria were included which 
meant that some conditions were represented in greater numbers than others. This approach 
meant that the least prevalent diagnoses could not be included within the statistical model 
which inherently leads to bias of results to the most prevalent conditions. While less 
prevalent conditions such as atlantoaxial instability, myopathies and vertebral fractures could 
not be statistically analysed they should still be considered by the clinician when presented 
cases of cervical hyperaesthesia. Although the variance in diagnosis prevalence within the 
study population is statistically accounted for within the logistic regression model, it does 
mean that the less prevalent conditions may lack the statistical power of the most prevalent 
disorders and thus associations with the variables studied may have been missed. In addition, 
the analysis of each diagnosis against the remainder of the study population is not 
characteristic of real-life clinical scenarios which could result in some statistical associations 
being overstated. Statistical based clinical reasoning can undoubtedly aid clinicians in 
identifying the most likely differential diagnosis for the most prevalent disorders. However, 
the clinical reasoning approach is limited in unusual disease presentations or uncommon 
disorders meaning that these remain difficult to identify in clinical practice.  
 
Conclusions 
Easy-to-recognise clinical characteristics from the history, physical and neurological 
examinations of dogs presenting with signs of cervical hyperaesthesia without concurrent 
neurological deficits can be evaluated to construct a prioritised list of differential diagnoses. 
Due to the innate variability of veterinary medicine the approach to managing patients 
presenting with cervical hyperaesthesia can never be reduced to a simple algorithm. 
However, it is hoped that the use of information from this study can be implemented by 
veterinary surgeons to improve the timeliness and accuracy of diagnosis in dogs with cervical 
hyperaesthesia.  Utilising clinical reasoning from the presenting features of the patient to 
produce a prioritised list of differential diagnoses, can assist the clinician in deciding upon 
the most appropriate diagnostic tests, treatment options and the potential need for referral in 
each patient.  
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